Tyra Bioscience News Today

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Wedbush reissued their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research note published on Friday, Benzinga reports. The brokerage currently has a $27.00 price objective on the stock. Wedbush also issued estimates for Tyra Biosciences’ Q2 2024 earnings at ($0.38) EPS. Separately, HC Wainwright upped their price objective on […]

GeoVax Labs (NASDAQ:GOVX – Get Rating) and Tyra Biosciences (NASDAQ:TYRA – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability. Risk & Volatility GeoVax Labs has a beta of […]

HC Wainwright reiterated their buy rating on shares of Tyra Biosciences (NASDAQ:TYRA – Get Rating) in a report published on Thursday, Benzinga reports. The brokerage currently has a $17.00 price target on the stock. HC Wainwright also issued estimates for Tyra Biosciences’ Q1 2024 earnings at ($0.40) EPS, Q2 2024 earnings at ($0.44) EPS, Q3 […]

Analysts predict that Tyra Biosciences Inc (NASDAQ:TYRA – Get Rating) will report ($0.20) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have made estimates for Tyra Biosciences’ earnings. The company is scheduled to announce its next quarterly earnings report on Monday, January 1st. On average, analysts expect […]

Tyra Biosciences’ (NASDAQ:TYRA – Get Rating) lock-up period will end on Monday, March 14th. Tyra Biosciences had issued 10,800,000 shares in its initial public offering on September 15th. The total size of the offering was $172,800,000 based on an initial share price of $16.00. After the expiration of the company’s lock-up period, company insiders and […]